Have a feature idea you'd love to see implemented?
Let us know!
LFST LifeStance Health Group Inc
Price (delayed)
$7.31
Market cap
$2.8B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.26
Enterprise value
$3.18B
Highlights
The quick ratio has soared by 50% YoY and by 7% from the previous quarter
LFST's EPS has surged by 50% year-on-year and by 37% since the previous quarter
Key stats
What are the main financial stats of LFST
Market
Valuations
Earnings
Shares outstanding
382.64M
Market cap
$2.8B
Enterprise value
$3.18B
Price to earnings (P/E)
N/A
Price to book (P/B)
1.95
Price to sales (P/S)
2.31
EV/EBIT
N/A
EV/EBITDA
59.68
EV/Sales
2.64
Revenue
$1.21B
EBIT
-$64.38M
EBITDA
$53.31M
Free cash flow
$35.06M
Per share
Balance sheet
Liquidity
EPS
-$0.26
Free cash flow per share
$0.09
Book value per share
$3.76
Revenue per share
$3.17
TBVPS
$1.63
Total assets
$2.11B
Total liabilities
$670.85M
Debt
$486.69M
Equity
$1.44B
Working capital
$69.51M
Debt to equity
0.34
Current ratio
1.32
Quick ratio
1.2
Net debt/EBITDA
7.21
Margins
Efficiency
Dividend
EBITDA margin
4.4%
Gross margin
31.2%
Net margin
-7.9%
Operating margin
-5.4%
Return on assets
-4.5%
Return on equity
-6.7%
Return on invested capital
-7.9%
Return on capital employed
-3.4%
Return on sales
-5.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LFST stock price
How has the LifeStance Health Group stock price performed over time
Intraday
1.25%
1 week
1.11%
1 month
3.84%
1 year
18.67%
YTD
-6.64%
QTD
4.43%
Financial performance
How have LifeStance Health Group's revenue and profit performed over time
Revenue
$1.21B
Gross profit
$376.28M
Operating income
-$64.94M
Net income
-$95.29M
Gross margin
31.2%
Net margin
-7.9%
The operating margin has surged by 73% year-on-year and by 55% since the previous quarter
The operating income has surged by 68% year-on-year and by 53% since the previous quarter
The net margin has soared by 58% YoY and by 40% from the previous quarter
LFST's net income is up by 49% YoY and by 37% from the previous quarter
Growth
What is LifeStance Health Group's growth rate over time
Valuation
What is LifeStance Health Group stock price valuation
P/E
N/A
P/B
1.95
P/S
2.31
EV/EBIT
N/A
EV/EBITDA
59.68
EV/Sales
2.64
LFST's EPS has surged by 50% year-on-year and by 37% since the previous quarter
LFST's price to book (P/B) is 15% higher than its last 4 quarters average of 1.7
The revenue has grown by 20% YoY and by 4.3% from the previous quarter
The price to sales (P/S) is 5% more than the last 4 quarters average of 2.2
Efficiency
How efficient is LifeStance Health Group business performance
LFST's return on sales has surged by 74% year-on-year and by 55% since the previous quarter
LFST's return on invested capital has surged by 67% year-on-year and by 52% since the previous quarter
LifeStance Health Group's return on assets has increased by 48% YoY and by 37% QoQ
LifeStance Health Group's return on equity has increased by 47% YoY and by 36% QoQ
Dividends
What is LFST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LFST.
Financial health
How did LifeStance Health Group financials performed over time
The quick ratio has soared by 50% YoY and by 7% from the previous quarter
LFST's current ratio is up by 20% YoY and by 8% QoQ
The debt is 66% less than the equity
The debt to equity has grown by 3% YoY but it has contracted by 2.9% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.